GoAI
Get started
Neurogene Inc. logo

Neurogene Inc.

NGNE

NASDAQHealthcareBiotechnology

Open in GoAI

Previous close

$38.63

+$0.64 · +1.68%

Aug 21, 4:00 PM ET

NGNE company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

31

Expensive

Momentum

80

Gaining

Sentiment

63

Bullish

Risk resilience

43

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Industry
Biotechnology
Sector
Healthcare
Headquarters
US

Market position

Day range

Current $38.63

52-week range

Current $38.63

Open
$38.41
Previous close
$37.99
Volume
346.58K
Market cap
610.44M USD
50-day average
$34.8314
+10.91% above average
200-day average
$25.5961
+50.92% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
342.12M USD
P/E (TTM)
-7.01×
P/B (TTM)
4.01×
P/S (TTM)
0×
EV / EBITDA
-3.92×
Earnings yield
-20.72%
Free cash flow yield
-17.97%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
0.00%
Operating margin
0.00%
Net margin
0.00%
Return on equity
-34.11%
Return on assets
-31.31%
Return on invested capital
-37.50%

Financial health

Debt / equity
0.04×
Current ratio
16.56×

Financial statements

Income trends

Operating income

−103.21M USD-24.94%

Net income

−90.35M USD-20.24%
Income trends across reported periods−29.63M USD−56.38M USD−83.14M USD−109.9M USDOperating income, FY2021: −50.53M USDOperating income, FY2022: −56.52M USDOperating income, FY2023: −55.58M USDOperating income, FY2024: −82.61M USDOperating income, FY2025: −103.21M USDNet income, FY2021: −50.52M USDNet income, FY2022: −55.19M USDNet income, FY2023: −36.32M USDNet income, FY2024: −75.14M USDNet income, FY2025: −90.35M USDFY2021FY2022FY2023FY2024FY2025
Operating income FY2021 −50.53M USD. Operating income FY2022 −56.52M USD. Operating income FY2023 −55.58M USD. Operating income FY2024 −82.61M USD. Operating income FY2025 −103.21M USD. Net income FY2021 −50.52M USD. Net income FY2022 −55.19M USD. Net income FY2023 −36.32M USD. Net income FY2024 −75.14M USD. Net income FY2025 −90.35M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue—925K USD———
Cost of goods sold3.19M USD3.25M USD3.26M USD3.2M USD42.26M USD
Gross profit−3.19M USD−2.32M USD−3.26M USD−3.2M USD−42.26M USD
Research and development75.01M USD60.92M USD44.39M USD47.51M USD42.26M USD
Selling, general, and administrative25.13M USD22.61M USD11.19M USD9.01M USD8.27M USD
Operating expenses100.02M USD80.28M USD52.32M USD53.32M USD8.27M USD
Interest income11.55M USD8.47M USD2.95M USD1.34M USD19K USD
Interest expense5K USD12K USD12K USD2K USD—
Depreciation and amortization3.09M USD3.25M USD3.3M USD3.2M USD947K USD
Operating income−103.21M USD−82.61M USD−55.58M USD−56.52M USD−50.53M USD
Net income−90.35M USD−75.14M USD−36.32M USD−55.19M USD−50.52M USD

Company facts updated Aug 24, 2026.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

7 ratings
Strong buy00%
Buy686%
Hold114%
Sell00%
Strong sell00%

NGNE peers

Amgen Inc. logo

AMGN

Amgen Inc.

$439.33

+1.29%

Gilead Sciences, Inc. logo

GILD

Gilead Sciences, Inc.

$146.12

+1.87%

Vertex Pharmaceuticals Incorporated logo

VRTX

Vertex Pharmaceuticals Incorporated

$548.05

+1.44%

Intuitive Surgical, Inc. logo

ISRG

Intuitive Surgical, Inc.

$378.81

+1.16%

Sanofi logo

SNY

Sanofi

$45.85

+1.55%

Regeneron Pharmaceuticals, Inc. logo

REGN

Regeneron Pharmaceuticals, Inc.

$834.04

+0.90%

ETFs holding NGNE

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
11.08M
Weight
0.01%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$299.96—
iShares Biotechnology ETF logoiShares Biotechnology ETFIBB
Market value
4.5M
Weight
0.04%
AUM
10.75B USD
Expense ratio
0.44%
Price / 1D
$213.56—
iShares Russell 2000 Value ETF logoiShares Russell 2000 Value ETFIWN
Market value
3.97M
Weight
0.03%
AUM
14.66B USD
Expense ratio
0.24%
Price / 1D
$224.81—
Fidelity Enhanced Small Cap ETF logoFidelity Enhanced Small Cap ETFFESM
Market value
3.92M
Weight
0.06%
AUM
6.03B USD
Expense ratio
0.28%
Price / 1D
$47.94—
Vanguard Russell 2000 ETF logoVanguard Russell 2000 ETFVTWO
Market value
2.09M
Weight
0.01%
AUM
17.4B USD
Expense ratio
0.06%
Price / 1D
$121.25—
iShares Micro-Cap ETF logoiShares Micro-Cap ETFIWC
Market value
1.48M
Weight
0.10%
AUM
1.53B USD
Expense ratio
0.60%
Price / 1D
$198.39—
Vanguard Health Care ETF logoVanguard Health Care ETFVHT
Market value
1.03M
Weight
0.00%
AUM
20.9B USD
Expense ratio
0.09%
Price / 1D
$327.7—
Avantis U.S. Small Cap Equity ETF logoAvantis U.S. Small Cap Equity ETFAVSC
Market value
968.71K
Weight
0.03%
AUM
3.16B USD
Expense ratio
0.25%
Price / 1D
$73.84—

Continue in GoAI

Research NGNE

research.disclaimer